Share

Latest Documents


  • 10-March-2023

    English

    Collaborative mechanisms for sustainable health innovation - The case of vaccines and antibiotics

    The provision of key health technologies and products such as vaccines and antibiotics is insufficient in purely competitive and volume-based markets, requiring new revenue streams for sustainability. Recent developments in health innovation suggest that innovative collaborative mechanisms can be effective in addressing this issue. In the domains of vaccines and antibiotics, these approaches should incorporate shared research investment, long-term access planning, the provision of manufacturing infrastructure, supply chains, and financial returns. Collaborative approaches such as subscription models could be piloted at the regional level, while other models could be developed to delink innovation, manufacturing, and access from sales volume and revenue. Finally, blended finance instruments from the development field could encourage greater collaboration among established and emerging stakeholders in health innovation. These stakeholders should work together to create, test, access, and implement more collaborative approaches to health innovation to share upfront investments, mitigate risks of failure, and accelerate market access.

  • 4-November-2022

    English

    Building back a better innovation ecosystem in Ukraine

    Russia’s large-scale aggression is aggravating the long-term trend of underinvestment in R&D in Ukraine through direct war-related destruction of physical infrastructure and human capital, as well as accelerated brain drain. About a quarter of the research workforce had left the country as of August 2022.

    Related Documents

  • 4-November-2022

    English

    Key nanotechnology indicators

    Indicators include nanotech firms, nanotech R&D, public sector R&D expenditure and nanotechnology patents.

    Related Documents

  • 4-November-2022

    English

    Key biotechnology indicators

    Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.

    Related Documents

  • 21-October-2022

    English

    ANBERD (Analytical Business Enterprise Research and Development) database

    Data set on R&D expenditure by industry which addresses the problems of international comparability and breaks in the time series of the official business enterprise R&D data.

    Related Documents

  • 4-October-2022

    English

    OECD Reviews of Innovation Policy

    These reviews offer a comprehensive assessment of the innovation system of individual OECD member and non-member countries, focusing on the role of government. They provide concrete recommendations on how to improve policies which impact innovation performance.

    Related Documents

  • 22-September-2022

    English

    Main Science and Technology Indicators

    A timely set of indicators that reflect the level and structure of the efforts undertaken by OECD member countries and selected non-member economies in the field of science and technology.

    Related Documents

  • 15-September-2022

    English

    Earth’s Orbits at Risk - The Economics of Space Sustainability

    Society’s dependence on space infrastructure is at a critical juncture. Public and private actors worldwide are planning to launch tens of thousands of satellites into Earth’s orbit in the next five years. This will greatly expand and enrich the use of space resources, but it will also result in more crowded orbits and greater risk of damage from satellite collision and space debris. As satellite launches continue to multiply and concerns grow, the long-term sustainability of space-based infrastructure on orbit and beyond is set to emerge as an increasingly important space policy issue of the 21st century. This publication takes stock of the growing socio-economic dependence of our modern societies on space assets, and the general threats to space-based infrastructure from debris in particular. Notably, it provides fresh insights into the value of space-based infrastructure and the potential costs generated by space debris, drawing on new academic research developed especially for the OECD project on the economics of space sustainability.

  • 7-September-2022

    English

    Implementing the OECD Frascati Manual - Proposed reference items for business R&D surveys

    This working paper contains guidance, of a voluntary and indicative nature, on the implementation of business R&D surveys, consistent with the standards and proposals contained in the OECD Frascati Manual. The document is oriented towards experts in charge of designing and implementing official R&D surveys, but may be also valuable to academics and researchers with a similar practical orientation. It aims to promote widespread testing and implementation in view of a potential future revision of the Frascati Manual or release of complementary annexes.

  • 25-August-2022

    English

    Towards a new vision of innovation through COVID-19? - A comparative reading of 11 countries’ strategies

    This paper discusses how countries’ vision for science, technology and innovation (STI) priorities has evolved through COVID-19. The analysis was conducted on a sample of 171 STI strategy documents from 11 countries that were released between 2013 and 2021. Depending on the context, these documents seek to build consensus, manage actors, communicate or signal directions for policy, or achieve internal organisational motives. Most of the documents that have emerged since the COVID-19 crisis focus on a dominant ambitious societal goal and specific technologies to implement that goal. For example, environmental sustainability is a shared goal across different countries’ STI strategies, but its specific meaning differs. Most countries’ STI strategies also identify digitalisation as an important tool to achieve other socio-economic goals. Inclusivity is prominent in agendas reflecting country-specific circumstance. Improving resilience is a shared priority and increased in prominence with the COVID-19 experience.
    • 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>